DE60234772D1 - Gruppe-b streptococcus antigene und entsprechende dna-fragmente - Google Patents

Gruppe-b streptococcus antigene und entsprechende dna-fragmente

Info

Publication number
DE60234772D1
DE60234772D1 DE60234772T DE60234772T DE60234772D1 DE 60234772 D1 DE60234772 D1 DE 60234772D1 DE 60234772 T DE60234772 T DE 60234772T DE 60234772 T DE60234772 T DE 60234772T DE 60234772 D1 DE60234772 D1 DE 60234772D1
Authority
DE
Germany
Prior art keywords
streptococcus
group
antigenic
dna fragments
corresponding dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60234772T
Other languages
German (de)
English (en)
Inventor
Denis Martin
Stephane Rioux
Bernard R Brodeur
Josee Hamel
Martine Boyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ID Biomedical Corp of Quebec
Original Assignee
ID Biomedical Corp of Quebec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ID Biomedical Corp of Quebec filed Critical ID Biomedical Corp of Quebec
Application granted granted Critical
Publication of DE60234772D1 publication Critical patent/DE60234772D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60234772T 2001-07-06 2002-07-05 Gruppe-b streptococcus antigene und entsprechende dna-fragmente Expired - Lifetime DE60234772D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30310101P 2001-07-06 2001-07-06
PCT/CA2002/001019 WO2003004650A2 (en) 2001-07-06 2002-07-05 Group b streptococcus antigens and corresponding dna fragments

Publications (1)

Publication Number Publication Date
DE60234772D1 true DE60234772D1 (de) 2010-01-28

Family

ID=23170538

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60234772T Expired - Lifetime DE60234772D1 (de) 2001-07-06 2002-07-05 Gruppe-b streptococcus antigene und entsprechende dna-fragmente

Country Status (10)

Country Link
US (2) US7393536B2 (enExample)
EP (1) EP1407023B1 (enExample)
JP (2) JP4374245B2 (enExample)
AT (1) ATE452191T1 (enExample)
AU (1) AU2002317107B2 (enExample)
BR (1) BR0210875A (enExample)
CA (1) CA2453062C (enExample)
DE (1) DE60234772D1 (enExample)
ES (1) ES2337773T3 (enExample)
WO (1) WO2003004650A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002034771A2 (en) * 2000-10-27 2002-05-02 Chiron Srl Nucleic acids and proteins from streptococcus groups a & b
AU1686302A (en) * 2000-12-21 2002-07-01 Shire Biochem Inc Streptococcus pyogenes antigens and corresponding dna fragments
JP2005514052A (ja) * 2001-12-21 2005-05-19 チルドレンズ ホスピタル アンド レジオナル メディカル センター B群連鎖球菌の新規の細胞表面プロテアーゼの使用
US8877909B2 (en) 2011-04-04 2014-11-04 Intelligent Medical Devices, Inc. Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantitation, monitoring, screening, and sequencing of group B Streptococcus
KR101675382B1 (ko) 2015-04-07 2016-11-14 (주) 씨에스코리아 황토보드 제조방법 및 그에 의해 제조되는 황토보드

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994006465A1 (en) 1992-09-16 1994-03-31 The University Of Tennessee Research Corporation Antigen of hybrid m protein and carrier for group a streptococcal vaccine
ATE349527T1 (de) 1997-09-12 2007-01-15 Univ Tennessee Res Foundation Gruppe a streptokokken-impfstoff
ATE394489T1 (de) * 1998-12-23 2008-05-15 Id Biomedical Corp Streptococcus antigene
GB9921125D0 (en) 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
WO2002034771A2 (en) * 2000-10-27 2002-05-02 Chiron Srl Nucleic acids and proteins from streptococcus groups a & b
FR2824074A1 (fr) 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
AU2002351623A1 (en) 2001-12-20 2003-07-09 Shire Biochem Inc. Streptococcus antigens

Also Published As

Publication number Publication date
US20040242844A1 (en) 2004-12-02
AU2002317107B2 (en) 2008-06-12
ES2337773T3 (es) 2010-04-29
WO2003004650A3 (en) 2003-05-30
US7393536B2 (en) 2008-07-01
EP1407023A2 (en) 2004-04-14
BR0210875A (pt) 2004-06-22
JP5194199B2 (ja) 2013-05-08
JP2009240316A (ja) 2009-10-22
US20090042794A1 (en) 2009-02-12
CA2453062A1 (en) 2003-01-16
ATE452191T1 (de) 2010-01-15
JP2005501534A (ja) 2005-01-20
EP1407023B1 (en) 2009-12-16
CA2453062C (en) 2013-04-02
WO2003004650A2 (en) 2003-01-16
JP4374245B2 (ja) 2009-12-02
US7740870B2 (en) 2010-06-22

Similar Documents

Publication Publication Date Title
UY26783A1 (es) Antígenos de estreptococo.
NO20004161L (no) Gruppe B streptokoccus antigener
DE60036698D1 (de) Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
FR21C1005I2 (fr) Antigenes de streptococcus pyogenes et fragments d'adn correspondants
ATE463575T1 (de) Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
NO20041917L (no) Spesifikke midler som binder humant angiopoietin-2
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
DE602004024542D1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
DE60037900D1 (de) Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
WO2001081380A3 (en) Immunogenic pneumococcal protein and vaccine compositions thereof
ATE412750T1 (de) Antigen aus streptococcus pyogenes
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
DK1037916T3 (da) Erythrovirus og dets anvendelser
WO2003068813A3 (en) Group b streptococcus antigen
BR0207447A (pt) Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina
BR0111785A (pt) Composições e métodos para tratamento de candidìase
WO2002088178A8 (en) Antigens of group b streptococcus and corresponding dna fragments
WO2002079475A3 (en) Streptococcus pyogenes antigens and corresponding dna fragments
ATE547527T1 (de) Gruppe b streptococcus bvh-a2 und bvh-a3 antigene
ATE341613T1 (de) Fluordesoxyuridin-resistente streptococcus gordonii stämme
WO2002055019A3 (en) Methods for ameliorating childhood infections
SE0100412D0 (sv) Novel human poly(A) polymerase

Legal Events

Date Code Title Description
8364 No opposition during term of opposition